Is it conceivable to reduce the harmful effects of the “vaccine” spike proteins produced by covid with anything as basic as nutrition? Recent research that was just published in a scientific journal appears to provide support for this hypothesis.
The dietary supplements bromelain & acetylcysteine (BromAc) are quite popular, and they are both capable of unraveling the structures that keep spike proteins together, which essentially neutralizes them. Australian researchers investigated the effects of these two supplements.
The spike glycoprotein plus envelope protein of the acute respiratory syndromes coronavirus, commonly known as SARS-CoV-2, is what defines the virus. These proteins include disulfide bridges, which help the virus remain stable. They cause infection by binding to the ACE2 receptor on the surface of host cells that are found in the nasal mucosa.
According to the findings of the research group, a BromAc treatment is capable of “synergistic action against glycoproteins.” This occurs when the nutritional duo breaks apart all the glycosidic linkages as well as disulfide bonds, thereby decreasing or even eliminating the capacity of spike proteins to induce covid infection.
As a point of clarification, these very same spike proteins can be found in all of the so-called “vaccines” that are now on the market for the general public to purchase. Some people believe that the injections are the only way to obtain these spike proteins and that covid is a myth because the said virus has not been identified in human patients. Others contend that the injections are the only way to obtain these spike proteins.
According to the text of the publication, “We intended to assess the effect that BromAc might have on the spike & envelope proteins, as well as its potential to diminish infectivity in host cells.” BromAc was responsible for the disruption of the recombinant SARS-CoV-2 spike and envelope proteins. Acetylcysteine was able to minimize the number of disulfide linkages in the spike and envelope proteins.
“SARS-CoV-2 displayed a concentration-dependent inactivation following BromAc treatment but not by single agents in vitro whole viral culture from both wild-type & spike mutants,” Imminent clinical trials by nasal administration in individuals with early SARS-CoV-2 infection will take place.
Is BromAc an all-natural remedy for the protein damage caused by the covid jab spike?
Treatment using acetylcysteine alone did not reveal any changes to the spike proteins; however, treatment with acetylcysteine + bromelain, or BromAc, at 50 and 100 g/20 mg/mL and 50 and 100 g/mL, respectively, caused substantial changes to the spike proteins.
According to the research study, “Treatment with Acetylcysteine on the envelope protein did not modify the protein,” whereas “treatment with Bromelain at 50 and 100 g/mL and BromAc at 50 and 100 g/20 mg/mL likewise resulted in near full and complete fragmentation,” respectively.
In other words, the mixture of these two nutrient content at the levels depicted in the study led to the destabilization or unraveling of covid spike proteins, which is excellent news for everyone who received a vaccination, as well as for ones who may have had spike protein “shed” on them from a fully vaccinated person.
Due to the fact that the experiments were carried out in vitro, also known as in a petri dish, more research is required to evaluate whether or not identical results can be produced in genuine human test participants. In spite of this, the researchers describe the findings as “encouraging,” suggesting that there is a natural answer to the problem of covid spike proteins, which are immune to the majority of other possible treatments.
According to the authors’ findings, “there is presently no effective therapeutic therapy for early SARS-CoV-2 with the objective of avoiding illness development.” Due to its potential to change the complex glycoprotein structures, BromAc is now undergoing clinical research for the treatment of mucinous malignancies the authors. It was shown that BromAc, when tested on SARS-CoV-2 spike & envelope proteins that were stabilized by disulfide bonds, may stimulate the unfolding of transgenic spike & envelope proteins by lowering the number of disulfide stabilizer bridges.
“BromAc also demonstrated an inhibitory impact on wild-type or spike mutation SARS-CoV-2 by inhibiting the virus’s ability to replicate in vitro,” the study said. Therefore, BromAc could be a successful treatment drug for early SARS-CoV-2 contamination, notwithstanding mutations. Additionally, BromAc could even have promise as a preventive in patients who are at high risk of becoming infected.
Please DON’T believe me or anyone, judge for yourself, and seek advice from YOUR personal doctor. You can read the full story for free at ResearchGate.net.